Rybelsus is another form of semaglutide, but unlike Wegovy and Ozempic (which are weekly injections), it comes as a pill taken once daily
By increasing your metabolism and digestive tract activity, your body works at a higher level than usual
14 regularly-scheduled council meeting, held in person and online
1 Press release, July 3, 2026, ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI 2 Press Release, July 5, 2023, ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing 3 Press Release, July 25, 2025, ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone Lispro (THDB0206 injection) in people with T2D 4 Press Release, October 15, 2025, ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone Lispro (THDB0206 injection) in people with T1D 5 GMP = Good Manufacturing Practices 6 P ress Release, November 12, 2025, ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity - AdoXLong - and Provides an Update on its BioChaperone Platform Adocia Olivier Soula CEO [email protected] +33 (0)4 72 610 610 www.adocia.com Maarc Adocia Press & Investor Relations Bruno Arabian Yasmine Duval Thomas Rolnik [email protected] + 33 (0)6 87 88 47 26 View source version on businesswire.com: The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties
Location 133 Western Road, Haywards Heath, West Sussex RH16 3LH Phone 07809 414856 [email protected] Hours Monday Saturday 8am-8pm Sundays on request
